ANAGALIS ARVENSIS GRAN AND GLOB 5CH-30CH DIN 00744778
Status: Cancelled Post Market
Holder: DOLISOS LABORATOIRES S.A.
Molecule: PIMPINELLA SAXIFRAGA
Available to quote
Health Canada record
| Active ingredient(s) | PIMPINELLA SAXIFRAGA 1 DH |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | HOMEOPATHIC |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1987 |
| Current status date | 09-Feb-1998 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PIMPINELLA SAXIFRAGA
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00745898 | ANAGALLIS ARVENSIS DROPS 5CH-30CH | DOLISOS LABORATOIRES S.A. | Drops | PIMPINELLA SAXIFRAGA 1 X | Cancelled Post Market |
| 02066599 | PIMPINELLA ALBA-INJEEL FORTE LIQ (4D,10D,30D,200D/1.1ML) | BIOLOGISCHE HEILMITTEL HEEL GMBH | Liquid | PIMPINELLA SAXIFRAGA 4 D | Cancelled Post Market |
| 02065959 | PIMPINELLA ALBA-INJEEL LIQ (10D,30D,200D/1.1ML) | BIOLOGISCHE HEILMITTEL HEEL GMBH | Liquid | PIMPINELLA SAXIFRAGA 10 D | Cancelled Post Market |
| 02193620 | PIMPINELLA SAXIFRAGA LIQUID (S#1256)-LIQ | TOTAL HEALTH CENTRE | Liquid | PIMPINELLA SAXIFRAGA 1 X | Cancelled Post Market |